BioSynthema Inc.

BioSynthema Inc. (BioSynthema) is a privately held medical device company. The company is principally engaged in the development, manufacture and discover of unique pharmaceuticals targeting the cells over expressed in cancer cells. It develops compounds for diagnosis and treatment of neuroendocrine tumors. BioSynthema is also specialized in receptor targeted peptides which have diagnostic and therapeutic applications. The company has a research and development laboratory at St. Louis where it does research operations to discover new compounds for the treatment of cancer and neuroendocrine tumors. BioSynthema is headquartered in Missouri, the US.

Street: 
4041 Forest Park Avenue
City: 
Saint Louis
Postcode: 
63108
Federal State : 
United States
WebSite: 
www.biosynthema.com
Fax: 
1-314-6156901

Company Index Score

Current Index Score Historical Index Score
  • BioSynthema Inc. currently scores 50 % in the index.
  • BioSynthema Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • BioSynthema Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets